BMS paid $150m upfront to enter a collaborative development deal for bispecific ...
Poseida Therapeutics has received RMAT designation from the US FDA for its CAR-T...
The company claims that the FTC’s July 2024 report is riddled with “false and mi...
The clinical hold was placed on three studies investigating azenosertib in June ...
The partnership will see AI-enabled screening used to address bioavailability is...
Bicara was one of three biotechs that went public last week in one of the busies...
Eli Lilly and Company has announced the FDA approval of EBGLYSS for treating ato...
The published belrestotug/dostarlimab data is still too immature to prove the co...
GlobalData forecasts predict Enhertu will retain its dominant market position in...
Oncternal is halting the development of two cancer candidates, ONCT-534 and ONCT...
The company plans to focus its resources on conducting clinical trials for CD388...
Sobi and Enable Injections have entered an agreement for the development and dis...
The US Food and Drug Administration (FDA) has approved Roche's Tecentriq Hybreza...
R&D frameworks are in place for the next pandemic-causing pathogen, but ways to ...
Sanofi has signed a licensing agreement with RadioMedix and Orano Med to advance...
Lilly has announced a significant expansion of its manufacturing presence in Ire...
